 | • レポートコード：20QY06-02206 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、全ワクチンのグローバル市場について種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他）、用途別（大人用、子供用）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・全ワクチン市場の概要 ・世界の主要地域別全ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の全ワクチン市場規模2015-2026：種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他） ・世界の全ワクチン市場規模2015-2026：用途別（大人用、子供用） ・全ワクチンの北米市場規模2015-2020 ・全ワクチンのヨーロッパ市場規模2015-2020 ・全ワクチンの中国市場規模2015-2020 ・全ワクチンの日本市場規模2015-2020 ・全ワクチンの東南アジア市場規模2015-2020 ・全ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CNBG、ChengDa Bio、Changsheng Life、Zhifei、SINOVAC BIOTECH、NuoCheng Bio、Hualan Bio、Kangtai、SANOFI PASTEUR、Novartis、GSK） ・全ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・全ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global All Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global All Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or “wild” pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the All Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the All Vaccine industry.
Based on our recent survey, we have several different scenarios about the All Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of All Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global All Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global All Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global All Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global All Vaccine market. The report also includes nautical information, where it shows All Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global All Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global All Vaccine market.
The average price of China All Vaccine is in the increasing trend, from 2.93 USD/Dose in 2012 to 4.27 USD/Dose in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
Geographical Analysis:
Based on region, the global All Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global All Vaccine market are
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR
Novartis
GSK
Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others
Segment by Application
For Adult
For Child
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global All Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global All Vaccine market.
• The market share of the global All Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global All Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global All Vaccine market.
1 All Vaccine Market Overview
1.1 All Vaccine Product Scope
1.2 All Vaccine Segment by Type
1.2.1 Global All Vaccine Sales by Type (2020-2026)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 All Vaccine Segment by Application
1.3.1 Global All Vaccine Sales Comparison by Application (2020-2026)
1.3.2 For Adult
1.3.3 For Child
1.4 All Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global All Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global All Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global All Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): All Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the All Vaccine Industry
1.5.1.1 All Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and All Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for All Vaccine Players to Combat Covid-19 Impact
2 All Vaccine Estimate and Forecast by Region
2.1 Global All Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global All Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global All Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global All Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global All Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global All Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global All Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States All Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe All Vaccine Estimates and Projections (2015-2026)
2.4.3 China All Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan All Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia All Vaccine Estimates and Projections (2015-2026)
2.4.6 India All Vaccine Estimates and Projections (2015-2026)
3 Global All Vaccine Competition Landscape by Players
3.1 Global Top All Vaccine Players by Sales (2015-2020)
3.2 Global Top All Vaccine Players by Revenue (2015-2020)
3.3 Global All Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in All Vaccine as of 2019)
3.4 Global All Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers All Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key All Vaccine Players (Opinion Leaders)
4 Global All Vaccine Market Size by Type
4.1 Global All Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global All Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global All Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global All Vaccine Price by Type (2014-2020)
4.2 Global All Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global All Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global All Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global All Vaccine Price Forecast by Type (2021-2026)
5 Global All Vaccine Market Size by Application
5.1 Global All Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global All Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global All Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global All Vaccine Price by Application (2015-2020)
5.2 Global All Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global All Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global All Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global All Vaccine Price Forecast by Application (2021-2026)
3 North America All Vaccine Market Facts & Figures
3.2 North America All Vaccine Sales Market Share by Company (2015-2020)
3.3 North America All Vaccine Sales Market Share by Type (2015-2020)
3.4 North America All Vaccine Sales Market Share by Application (2015-2020)
4 Europe All Vaccine Market Facts & Figures
4.2 Europe All Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe All Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe All Vaccine Sales Market Share by Application (2015-2020)
5 China All Vaccine Market Facts & Figures
5.2 China All Vaccine Sales Market Share by Company (2015-2020)
5.3 China All Vaccine Sales Market Share by Type (2015-2020)
5.4 China All Vaccine Sales Market Share by Application (2015-2020)
6 Japan All Vaccine Market Facts & Figures
6.2 Japan All Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan All Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan All Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia All Vaccine Market Facts & Figures
7.2 Southeast Asia All Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia All Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia All Vaccine Sales Market Share by Application (2015-2020)
8 India All Vaccine Market Facts & Figures
8.2 India All Vaccine Sales Market Share by Company (2015-2020)
8.3 India All Vaccine Sales Market Share by Type (2015-2020)
8.4 India All Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in All Vaccine Business
12.1 CNBG
12.1.1 CNBG All Vaccine Corporation Information
12.1.2 CNBG All Vaccine Business Overview and Total Revenue
12.1.3 CNBG All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CNBG All Vaccine Products Offered
12.1.5 CNBG Recent Development
12.2 ChengDa Bio
12.2.1 ChengDa Bio All Vaccine Corporation Information
12.2.2 ChengDa Bio All Vaccine Business Overview and Total Revenue
12.2.3 ChengDa Bio All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 ChengDa Bio All Vaccine Products Offered
12.2.5 ChengDa Bio Recent Development
12.3 Changsheng Life
12.3.1 Changsheng Life All Vaccine Corporation Information
12.3.2 Changsheng Life All Vaccine Business Overview and Total Revenue
12.3.3 Changsheng Life All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Changsheng Life All Vaccine Products Offered
12.3.5 Changsheng Life Recent Development
12.4 Zhifei
12.4.1 Zhifei All Vaccine Corporation Information
12.4.2 Zhifei All Vaccine Business Overview and Total Revenue
12.4.3 Zhifei All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Zhifei All Vaccine Products Offered
12.4.5 Zhifei Recent Development
12.5 SINOVAC BIOTECH
12.5.1 SINOVAC BIOTECH All Vaccine Corporation Information
12.5.2 SINOVAC BIOTECH All Vaccine Business Overview and Total Revenue
12.5.3 SINOVAC BIOTECH All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 SINOVAC BIOTECH All Vaccine Products Offered
12.5.5 SINOVAC BIOTECH Recent Development
12.6 NuoCheng Bio
12.6.1 NuoCheng Bio All Vaccine Corporation Information
12.6.2 NuoCheng Bio All Vaccine Business Overview and Total Revenue
12.6.3 NuoCheng Bio All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 NuoCheng Bio All Vaccine Products Offered
12.6.5 NuoCheng Bio Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio All Vaccine Corporation Information
12.7.2 Hualan Bio All Vaccine Business Overview and Total Revenue
12.7.3 Hualan Bio All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hualan Bio All Vaccine Products Offered
12.7.5 Hualan Bio Recent Development
12.8 Kangtai
12.8.1 Kangtai All Vaccine Corporation Information
12.8.2 Kangtai All Vaccine Business Overview and Total Revenue
12.8.3 Kangtai All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Kangtai All Vaccine Products Offered
12.8.5 Kangtai Recent Development
12.9 SANOFI PASTEUR
12.9.1 SANOFI PASTEUR All Vaccine Corporation Information
12.9.2 SANOFI PASTEUR All Vaccine Business Overview and Total Revenue
12.9.3 SANOFI PASTEUR All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 SANOFI PASTEUR All Vaccine Products Offered
12.9.5 SANOFI PASTEUR Recent Development
12.10 Novartis
12.10.1 Novartis All Vaccine Corporation Information
12.10.2 Novartis All Vaccine Business Overview and Total Revenue
12.10.3 Novartis All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis All Vaccine Products Offered
12.10.5 Novartis Recent Development
12.11 GSK
12.11.1 GSK All Vaccine Corporation Information
12.11.2 GSK All Vaccine Business Overview and Total Revenue
12.11.3 GSK All Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GSK All Vaccine Products Offered
12.11.5 GSK Recent Development
13 All Vaccine Manufacturing Cost Analysis
13.1 All Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of All Vaccine
13.4 All Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 All Vaccine Distributors List
14.3 All Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global All Vaccine Sales (M Dose) Growth Rate by Type (2020-2026)
Table 2. Global All Vaccine Sales (M Dose) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four All Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for All Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for All Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market All Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global All Vaccine Sales (M Dose) by Region (2015-2020)
Table 10. Global All Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global All Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global All Vaccine Revenue Share by Region (2015-2020)
Table 13. Global All Vaccine Sales (M Dose) Forecast by Region (2021-2026)
Table 14. Global All Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global All Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global All Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global All Vaccine (M Dose) of Key Companies (2015-2020)
Table 18. Global All Vaccine Sales Share by Company (2015-2020)
Table 19. Global All Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global All Vaccine Revenue Share by Company (2015-2020)
Table 21. Global All Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in All Vaccine as of 2019)
Table 22. Global All Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers All Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers All Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key All Vaccine Players
Table 27. Global All Vaccine Sales (M Dose) by Type (2015-2020)
Table 28. Global All Vaccine Sales Share by Type (2015-2020)
Table 29. Global All Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global All Vaccine Price (M Dose) by Type (2015-2020)
Table 31. Global All Vaccine Sales Share by Type (2021-2026)
Table 32. Global All Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global All Vaccine Revenue Share by Type (2021-2026)
Table 34. Global All Vaccine Price (M Dose) by Type (2021-2026)
Table 35. Global All Vaccine Sales (M Dose) by Application (2015-2020)
Table 36. Global All Vaccine Sales Share by Application (2015-2020)
Table 37. Global All Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global All Vaccine Price (M Dose) by Application (2015-2020)
Table 39. Global All Vaccine Sales (M Dose) by Application (2021-2026)
Table 40. Global All Vaccine Sales Share by Application (2021-2026)
Table 41. Global All Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global All Vaccine Revenue Share by Application (2021-2026)
Table 43. Global All Vaccine Price (M Dose) by Application (2021-2026)
Table 44. United States All Vaccine Sales (M Dose) by Company (2015-2020)
Table 45. United States All Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States All Vaccine Sales (M Dose) by Type (2015-2020)
Table 47. United States All Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States All Vaccine Sales (M Dose) by Application (2015-2020)
Table 49. United States All Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe All Vaccine Sales (M Dose) by Company (2015-2020)
Table 51. Europe All Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe All Vaccine Sales (M Dose) by Type (2015-2020)
Table 53. Europe All Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe All Vaccine Sales (M Dose) by Application (2015-2020)
Table 55. Europe All Vaccine Sales Market Share by Type (2015-2020)
Table 56. China All Vaccine Sales (M Dose) by Company (2015-2020)
Table 57. China All Vaccine Sales Market Share by Company (2015-2020)
Table 58. China All Vaccine Sales (M Dose) by Type (2015-2020)
Table 59. China All Vaccine Sales Market Share by Type (2015-2020)
Table 60. China All Vaccine Sales (M Dose) by Application (2015-2020)
Table 61. China All Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan All Vaccine Sales (M Dose) by Company (2015-2020)
Table 63. Japan All Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan All Vaccine Sales (M Dose) by Type (2015-2020)
Table 65. Japan All Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan All Vaccine Sales (M Dose) by Application (2015-2020)
Table 67. Japan All Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia All Vaccine Sales (M Dose) by Company (2015-2020)
Table 69. Southeast Asia All Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia All Vaccine Sales (M Dose) by Type (2015-2020)
Table 71. Southeast Asia All Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia All Vaccine Sales (M Dose) by Type (2015-2020)
Table 73. Southeast Asia All Vaccine Sales Market Share by Application (2015-2020)
Table 74. India All Vaccine Sales (M Dose) by Company (2015-2020)
Table 75. India All Vaccine Sales Market Share by Company (2015-2020)
Table 76. India All Vaccine Sales (M Dose) by Type (2015-2020)
Table 77. India All Vaccine Sales Market Share by Type (2015-2020)
Table 78. India All Vaccine Sales (M Dose) by Application (2015-2020)
Table 79. India All Vaccine Sales Market Share by Application (2015-2020)
Table 80. CNBG Corporation Information
Table 81. CNBG Description and Business Overview
Table 82. CNBG All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. CNBG All Vaccine Product
Table 84. CNBG Recent Development
Table 85. ChengDa Bio Corporation Information
Table 86. ChengDa Bio Description and Business Overview
Table 87. ChengDa Bio All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. ChengDa Bio All Vaccine Product
Table 89. ChengDa Bio Recent Development
Table 90. Changsheng Life Corporation Information
Table 91. Changsheng Life Description and Business Overview
Table 92. Changsheng Life All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Changsheng Life All Vaccine Product
Table 94. Changsheng Life Recent Development
Table 95. Zhifei Corporation Information
Table 96. Zhifei Description and Business Overview
Table 97. Zhifei All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Zhifei All Vaccine Product
Table 99. Zhifei Recent Development
Table 100. SINOVAC BIOTECH Corporation Information
Table 101. SINOVAC BIOTECH Description and Business Overview
Table 102. SINOVAC BIOTECH All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. SINOVAC BIOTECH All Vaccine Product
Table 104. SINOVAC BIOTECH Recent Development
Table 105. NuoCheng Bio Corporation Information
Table 106. NuoCheng Bio Description and Business Overview
Table 107. NuoCheng Bio All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. NuoCheng Bio All Vaccine Product
Table 109. NuoCheng Bio Recent Development
Table 110. Hualan Bio Corporation Information
Table 111. Hualan Bio Description and Business Overview
Table 112. Hualan Bio All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Hualan Bio All Vaccine Product
Table 114. Hualan Bio Recent Development
Table 115. Kangtai Corporation Information
Table 116. Kangtai All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Kangtai Description and Business Overview
Table 118. Kangtai All Vaccine Product
Table 119. Kangtai Recent Development
Table 120. SANOFI PASTEUR Corporation Information
Table 121. SANOFI PASTEUR All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. SANOFI PASTEUR Description and Business Overview
Table 123. SANOFI PASTEUR All Vaccine Product
Table 124. SANOFI PASTEUR Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Novartis All Vaccine Product
Table 129. Novartis Recent Development
Table . GSK Corporation Information
Table . GSK Description and Business Overview
Table . GSK All Vaccine Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . GSK All Vaccine Product
Table . GSK Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. All Vaccine Distributors List
Table 138. All Vaccine Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. All Vaccine Product Picture
Figure 2. Global All Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global All Vaccine Market Share by Application in 2020 & 2026
Figure 6. For Adult Examples
Figure 7. For Child Examples
Figure 8. Global All Vaccine Sales (M Dose) Growth Rate (2015-2026)
Figure 9. Global All Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global All Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global All Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global All Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States All Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States All Vaccine Sales (M Dose) Growth Rate (2015-2026)
Figure 15. Europe All Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe All Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China All Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China All Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan All Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan All Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia All Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia All Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India All Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India All Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest All Vaccine Players Market Share by Revenue in All Vaccine 2015 & 2019
Figure 26. All Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global All Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global All Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global All Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global All Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States All Vaccine Sales Market Share by Type in 2019
Figure 32. United States All Vaccine Sales Market Share by Type in 2019
Figure 33. Europe All Vaccine Sales Market Share by Company in 2019
Figure 34. Europe All Vaccine Sales Market Share by Type in 2019
Figure 35. Europe All Vaccine Sales Market Share by Application in 2019
Figure 36. China All Vaccine Sales Market Share by Company in 2019
Figure 37. China All Vaccine Sales Market Share by Type in 2019
Figure 38. China All Vaccine Sales Market Share by Application in 2019
Figure 39. Japan All Vaccine Sales Market Share by Company in 2019
Figure 40. Japan All Vaccine Sales Market Share by Type in 2019
Figure 41. Japan All Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia All Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia All Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia All Vaccine Sales Market Share by Application in 2019
Figure 45. India All Vaccine Sales Market Share by Company in 2019
Figure 46. India All Vaccine Sales Market Share by Type in 2019
Figure 47. India All Vaccine Sales Market Share by Application in 2019
Figure 48. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. ChengDa Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Changsheng Life Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zhifei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. SINOVAC BIOTECH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. NuoCheng Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Kangtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. SANOFI PASTEUR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of All Vaccine
Figure 61. Manufacturing Process Analysis of All Vaccine
Figure 62. All Vaccine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
ジフテリア・百日咳・破傷風ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria, Pertussis, and Tetanus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 2999.7 million by 2025, from USD 2595 million in 2019.…- 多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …
- A型肝炎ワクチンの世界市場レポート2020 Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines:…
- 肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…
- ジフテリア、破傷風、百日咳（DTaP）ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…